A detailed history of Cnb Bank transactions in Organon & Co. stock. As of the latest transaction made, Cnb Bank holds 64 shares of OGN stock, worth $942. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64
Previous 64 -0.0%
Holding current value
$942
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

BUY
$16.59 - $23.77 $1,061 - $1,521
64 New
64 $1,000
Q2 2022

Aug 10, 2022

BUY
$31.66 - $38.9 $3,387 - $4,162
107 New
107 $4,000
Q3 2021

Nov 02, 2021

SELL
$28.63 - $35.64 $2,576 - $3,207
-90 Closed
0 $0
Q2 2021

Jul 29, 2021

BUY
$28.45 - $38.0 $2,560 - $3,420
90 New
90 $3,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Cnb Bank Portfolio

Follow Cnb Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cnb Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cnb Bank with notifications on news.